Integral Health Asset Management
Latest statistics and disclosures from Integral Health Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ELV, CNC, LLY, CYTK, SNY, and represent 25.54% of Integral Health Asset Management's stock portfolio.
- Added to shares of these 10 stocks: LLY (+$24M), SNY (+$18M), CNC (+$17M), MCK (+$14M), DXCM (+$12M), GH (+$12M), ELV (+$11M), AZN (+$8.9M), PRGO (+$7.4M), ALNY (+$6.9M).
- Started 15 new stock positions in LXRX, PRGO, ICLR, KRYS, LLY, NSTG, CINC, XENE, DXCM, TDOC. MCK, DVA, MRNA, ALNY, SNY.
- Reduced shares in these 10 stocks: PFE (-$16M), GMED (-$13M), ACHC (-$9.8M), AMED (-$6.9M), CI (-$6.0M), , KROS, SGEN, , .
- Sold out of its positions in ACHC, AMED, Avalo Therapeutics, BIIB, CI, CMRX, DNLI, DOCS, GMED, INCY. INSP, ICPT, ISRG, KROS, NBIX, PMVP, PFE, DTIL, RGNX, Sierra Oncology, TFX.
- Integral Health Asset Management was a net buyer of stock by $142M.
- Integral Health Asset Management has $486M in assets under management (AUM), dropping by 26.50%.
- Central Index Key (CIK): 0001773206
Tip: Access up to 7 years of quarterly data
Positions held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv

Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 65 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Anthem (ELV) | 6.7 | $33M | +50% | 68k | 482.58 | |
Centene Corporation (CNC) | 6.1 | $30M | +133% | 350k | 84.61 | |
Eli Lilly & Co. (LLY) | 4.9 | $24M | NEW | 73k | 324.23 | |
Cytokinetics Com New (CYTK) | 4.2 | $21M | +11% | 525k | 39.29 | |
Sanofi Sponsored Adr (SNY) | 3.6 | $18M | NEW | 350k | 50.03 | |
Guardant Health (GH) | 3.2 | $16M | +285% | 385k | 40.34 | |
Astrazeneca Sponsored Adr (AZN) | 3.2 | $16M | +134% | 235k | 66.07 | |
Envista Hldgs Corp (NVST) | 3.1 | $15M | +54% | 386k | 38.54 | |
Chemocentryx | 2.9 | $14M | +43% | 574k | 24.78 | |
McKesson Corporation (MCK) | 2.8 | $14M | NEW | 42k | 326.22 | |
Sage Therapeutics (SAGE) | 2.7 | $13M | +32% | 412k | 32.30 | |
Tenet Healthcare Corp Com New (THC) | 2.7 | $13M | +92% | 251k | 52.56 | |
CVS Caremark Corporation (CVS) | 2.7 | $13M | +56% | 141k | 92.66 | |
Dex (DXCM) | 2.6 | $12M | NEW | 167k | 74.53 | |
BioMarin Pharmaceutical (BMRN) | 2.2 | $11M | +57% | 126k | 82.87 | |
PerkinElmer (PKI) | 2.0 | $9.6M | -9% | 68k | 142.22 | |
Zentalis Pharmaceuticals (ZNTL) | 2.0 | $9.6M | +58% | 340k | 28.10 | |
Merck & Co (MRK) | 2.0 | $9.5M | +39% | 104k | 91.17 | |
Shockwave Med (SWAV) | 1.8 | $9.0M | +56% | 47k | 191.16 | |
Kura Oncology (KURA) | 1.7 | $8.5M | +36% | 461k | 18.33 | |
Alkermes SHS (ALKS) | 1.6 | $7.8M | +4% | 262k | 29.79 | |
Amicus Therapeutics (FOLD) | 1.6 | $7.6M | +214% | 705k | 10.74 | |
Perrigo SHS (PRGO) | 1.5 | $7.4M | NEW | 183k | 40.57 | |
Relay Therapeutics (RLAY) | 1.5 | $7.3M | +33% | 436k | 16.75 | |
Alnylam Pharmaceuticals (ALNY) | 1.4 | $6.9M | NEW | 47k | 145.85 | |
Icon SHS (ICLR) | 1.4 | $6.8M | NEW | 31k | 216.70 | |
Uniqure Nv SHS (QURE) | 1.4 | $6.6M | +107% | 353k | 18.64 | |
Blueprint Medicines (BPMC) | 1.4 | $6.6M | -15% | 130k | 50.51 | |
Irhythm Technologies (IRTC) | 1.3 | $6.2M | -4% | 57k | 108.03 | |
1life Healthcare (ONEM) | 1.2 | $5.7M | +46% | 731k | 7.84 | |
Moderna (MRNA) | 1.2 | $5.7M | NEW | 40k | 142.85 | |
Seagen (SGEN) | 1.1 | $5.5M | -37% | 31k | 176.93 | |
Zai Lab Adr (ZLAB) | 1.1 | $5.4M | +108% | 157k | 34.68 | |
Agilon Health (AGL) | 1.0 | $5.0M | +31% | 231k | 21.83 | |
Crispr Therapeutics Namen Akt (CRSP) | 1.0 | $4.9M | -33% | 80k | 60.77 | |
Apellis Pharmaceuticals (APLS) | 0.9 | $4.5M | +149% | 99k | 45.22 | |
Intra Cellular Therapies (ITCI) | 0.9 | $4.5M | +95% | 78k | 57.08 | |
Zimmer Holdings (ZBH) | 0.9 | $4.4M | +39% | 42k | 105.06 | |
Intellia Therapeutics (NTLA) | 0.9 | $4.3M | +66% | 84k | 51.76 | |
Ptc Therapeutics I (PTCT) | 0.9 | $4.2M | +149% | 105k | 40.06 | |
DaVita (DVA) | 0.9 | $4.2M | NEW | 52k | 79.97 | |
Teladoc (TDOC) | 0.8 | $4.1M | NEW | 124k | 33.21 | |
Aclaris Therapeutics (ACRS) | 0.8 | $4.0M | +20% | 286k | 13.96 | |
Replimune Group (REPL) | 0.8 | $3.8M | +32% | 219k | 17.48 | |
Mirum Pharmaceuticals (MIRM) | 0.7 | $3.5M | +26% | 177k | 19.46 | |
Nevro (NVRO) | 0.7 | $3.4M | +56% | 78k | 43.83 | |
Krystal Biotech (KRYS) | 0.7 | $3.4M | NEW | 52k | 65.65 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.7 | $3.3M | -40% | 21k | 156.03 | |
Iteos Therapeutics (ITOS) | 0.7 | $3.2M | +84% | 157k | 20.60 | |
Reata Pharmaceuticals Cl A (RETA) | 0.7 | $3.2M | +198% | 104k | 30.39 | |
Xenon Pharmaceuticals (XENE) | 0.6 | $3.0M | NEW | 97k | 30.42 | |
Heron Therapeutics (HRTX) | 0.6 | $2.8M | 1.0M | 2.79 | ||
Akero Therapeutics (AKRO) | 0.6 | $2.7M | +44% | 288k | 9.45 | |
Arcturus Therapeutics Hldg I (ARCT) | 0.5 | $2.5M | +25% | 157k | 15.74 | |
Nanostring Technologies (NSTG) | 0.5 | $2.4M | NEW | 189k | 12.70 | |
Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.5 | $2.3M | +37% | 235k | 9.69 | |
Lifestance Health Group (LFST) | 0.4 | $2.1M | +150% | 376k | 5.56 | |
Si-bone (SIBN) | 0.4 | $2.1M | -33% | 157k | 13.20 | |
Insmed Com Par $.01 (INSM) | 0.4 | $2.1M | -30% | 104k | 19.72 | |
Atara Biotherapeutics (ATRA) | 0.3 | $1.6M | -30% | 209k | 7.79 | |
Forma Therapeutics Hldgs SHS | 0.2 | $896k | +44% | 130k | 6.89 | |
Cincor Pharma (CINC) | 0.2 | $787k | NEW | 42k | 18.85 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.1 | $558k | NEW | 300k | 1.86 | |
Magenta Therapeutics (MGTA) | 0.1 | $394k | +63% | 328k | 1.20 | |
Longboard Pharmaceuticals In (LBPH) | 0.0 | $177k | +20% | 57k | 3.09 |
Past Filings by Integral Health Asset Management
SEC 13F filings are viewable for Integral Health Asset Management going back to 2019
- Integral Health Asset Management 2022 Q2 filed Aug. 3, 2022
- Integral Health Asset Management 2022 Q1 filed May 12, 2022
- Integral Health Asset Management 2021 Q4 filed Feb. 2, 2022
- Integral Health Asset Management 2021 Q3 filed Nov. 12, 2021
- Integral Health Asset Management 2021 Q2 restated filed Aug. 30, 2021
- Integral Health Asset Management 2021 Q2 filed Aug. 13, 2021
- Integral Health Asset Management 2021 Q1 filed May 10, 2021
- Integral Health Asset Management 2020 Q4 filed Feb. 16, 2021
- Integral Health Asset Management 2020 Q3 filed Nov. 16, 2020
- Integral Health Asset Management 2020 Q2 filed Aug. 14, 2020
- Integral Health Asset Management 2020 Q1 filed May 15, 2020
- Integral Health Asset Management 2019 Q4 filed Feb. 13, 2020